TScan Therapeutics Inc. (TCRX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

TScan Therapeutics Inc.

NASDAQ: TCRX · Real-Time Price · USD
1.85
0.07 (3.93%)
At close: Sep 26, 2025, 3:59 PM
1.84
-0.54%
After-hours: Sep 26, 2025, 05:57 PM EDT

TScan Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
178.69M 133.36M 120.03M 161.41M
Short-Term Investments
111.42M 58.69M n/a n/a
Long-Term Investments
n/a n/a 5.04M 5.2M
Other Long-Term Assets
6.8M 6.68M 4.83M n/a
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
2.61M 2.19M 4.1M 4.25M
Total Current Assets
292.72M 194.24M 120.03M 165.65M
Property-Plant & Equipment
71.6M 71.23M 69.2M 17.26M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
78.4M 77.91M 79.06M 22.45M
Total Assets
371.12M 272.15M 199.09M 188.11M
Account Payables
4.28M 2.37M 2.91M 1.76M
Deferred Revenue
11.7M 10.14M 3.87M 11.41M
Short-Term Debt
4.57M 3.35M 3.68M 1.65M
Other Current Liabilities
2.35M 5.9M 1.11M 2.27M
Total Current Liabilities
35.96M 29.82M 17.3M 21.34M
Long-Term Debt
32.07M 26.7M 29.29M n/a
Other Long-Term Liabilities
135K n/a 49K 97K
Total Long-Term Liabilities
94.19M 91.46M 82.35M 5.99M
Total Liabilities
130.15M 121.28M 99.66M 27.33M
Total Debt
97.38M 92.43M 85.98M 6.04M
Book Value
240.97M 150.87M 99.43M 160.78M
Book Value Per Share
2.15 2.30 4.13 6.72
Common Stock
5K 5K 3K 3K
Retained Earnings
-375.1M -247.6M -158.38M -92.16M
Comprehensive Income
51K n/a -0.00 -188.11M
Shareholders Equity
240.97M 150.87M 99.43M 160.78M
Total Investments
111.42M 58.69M 5.04M 5.2M